Long-Term Statin Therapy and CSF Cholesterol Levels: Implications for Alzheimer’s Disease

Publisher： Karger

E-ISSN： 1421-9824|27|6|519-524

ISSN： 1420-8008

Source： Dementia and Geriatric Cognitive Disorders, Vol.27, Iss.6, 2009-05, pp. : 519-524

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Long-Term Efficacy and Safety of Celecoxib in Alzheimer’s Disease

By  

Dementia and Geriatric Cognitive Disorders, Vol. 23, Iss. 1, 2006-10 ,pp. : 8-21

Karger

Access to resources Recommend Favorite

Association between Statin Use and Alzheimer’s Disease

By  

Neuroepidemiology, Vol. 23, Iss. 1-2, 2004-01 ,pp. : 94-98

Karger

Access to resources Recommend Favorite

CSF Biomarkers for Alzheimer’s Disease: Levels of β-Amyloid, Tau, Phosphorylated Tau Relate to Clinical Symptoms and Survival

By  

Dementia and Geriatric Cognitive Disorders, Vol. 21, Iss. 3, 2006-02 ,pp. : 131-138

Karger

Access to resources Recommend Favorite

Polymorphism in apoA1 Influences High-Density Lipoprotein Cholesterol Levels but Is Not a Major Risk Factor of Alzheimer’s Disease

By  

Dementia and Geriatric Cognitive Disorders Extra, Vol. 1, Iss. 1, 2012-01 ,pp. : 249-257

Karger

Access to resources Recommend Favorite

Long-Term Safety and Efficacy of Donepezil in Patients with Severe Alzheimer’s Disease: Results from a 52-Week, Open-Label, Multicenter, Extension Study in Japan

By  

Dementia and Geriatric Cognitive Disorders, Vol. 27, Iss. 3, 2009-02 ,pp. : 232-239

Karger

Access to resources Recommend Favorite